de Haan L - Search Results

1

Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study.

Trotta G, Rodriguez V, Quattrone D, Spinazzola E, Tripoli G, Gayer-Anderson C, Freeman TP, Jongsma HE, Sideli L, Aas M, Stilo SA, La Cascia C, Ferraro L, La Barbera D, Lasalvia A, Tosato S, Tarricone I, D'Andrea G, Tortelli A, Schürhoff F, Szöke A, Pignon B, Selten JP, Velthorst E, de Haan L, Llorca PM, Rossi Menezes P, Del Ben CM, Santos JL, Arrojo M, Bobes J, Sanjuán J, Bernardo M, Arango C, Kirkbride JB, Jones PB, Richards A, Rutten BP, Van Os J, Austin-Zimmerman I, Li Z, Morgan C, Sham PC, Vassos E, Wong C, Bentall R, Fisher HL, Murray RM, Alameda L, Di Forti M; EU-GEI WP2 Group. Trotta G, et al. Among authors: de haan l. Psychol Med. 2023 Nov;53(15):7375-7384. doi: 10.1017/S0033291723000995. Epub 2023 May 4. Psychol Med. 2023. PMID: 38078747 Free PMC article.

2

Social disability at admission for a first psychosis does not predict clinical outcome at 5-year follow-up.

Velthorst E, Nieman DH, Meijer C, Linszen D, de Haan L. Velthorst E, et al. Among authors: de haan l. J Nerv Ment Dis. 2011 Jul;199(7):510-2. doi: 10.1097/NMD.0b013e3182214469. J Nerv Ment Dis. 2011. PMID: 21716066

3

Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine.

Machielsen M, Beduin AS, Dekker N; Genetic Risk and Outcome of Psychosis (GROUP) investigators; Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I. Machielsen M, et al. Among authors: de haan l. J Psychopharmacol. 2012 Jan;26(1):189-95. doi: 10.1177/0269881111408957. Epub 2011 Jul 18. J Psychopharmacol. 2012. PMID: 21768161

4

Factor analysis of the scale of prodromal symptoms: differentiating between negative and depression symptoms.

Klaassen RM, Velthorst E, Nieman DH, de Haan L, Becker HE, Dingemans PM, van de Fliert JR, van der Gaag M, Linszen DH. Klaassen RM, et al. Among authors: de haan l. Psychopathology. 2011;44(6):379-85. doi: 10.1159/000325169. Epub 2011 Aug 17. Psychopathology. 2011. PMID: 21847005

5

Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.

Meijer JH, Dekker N, Koeter MW, Quee PJ, van Beveren NJ, Meijer CJ; Genetic Risk and Outcome of Psychosis (GROUP) Investigators. Meijer JH, et al. Psychol Med. 2012 Apr;42(4):705-16. doi: 10.1017/S0033291711001656. Epub 2011 Sep 7. Psychol Med. 2012. PMID: 21899795

6

Cannabis use in patients at clinical high risk of psychosis: impact on prodromal symptoms and transition to psychosis.

van der Meer FJ, Velthorst E, Meijer CJ, Machielsen MW, de Haan L. van der Meer FJ, et al. Among authors: de haan l. Curr Pharm Des. 2012;18(32):5036-44. doi: 10.2174/138161212802884762. Curr Pharm Des. 2012. PMID: 22716158

7

To cut a short test even shorter: reliability and validity of a brief assessment of intellectual ability in schizophrenia--a control-case family study.

Velthorst E, Levine SZ, Henquet C, de Haan L, van Os J, Myin-Germeys I, Reichenberg A. Velthorst E, et al. Among authors: de haan l. Cogn Neuropsychiatry. 2013;18(6):574-93. doi: 10.1080/13546805.2012.731390. Epub 2012 Nov 20. Cogn Neuropsychiatry. 2013. PMID: 23167265

8

Transition to first episode psychosis in ultra high risk populations: does baseline functioning hold the key?

Velthorst E, Nelson B, Wiltink S, de Haan L, Wood SJ, Lin A, Yung AR. Velthorst E, et al. Among authors: de haan l. Schizophr Res. 2013 Jan;143(1):132-7. doi: 10.1016/j.schres.2012.10.025. Epub 2012 Nov 19. Schizophr Res. 2013. PMID: 23182438

9

Obsessive-compulsive symptoms in patients with schizophrenia: a naturalistic cross-sectional study comparing treatment with clozapine, olanzapine, risperidone, and no antipsychotics in 543 patients.

Scheltema Beduin AA, Swets M, Machielsen M, Korver N; Genetic Risk and Outcome of Psychosis Investigators. Scheltema Beduin AA, et al. J Clin Psychiatry. 2012 Nov;73(11):1395-402. doi: 10.4088/JCP.11m07164. J Clin Psychiatry. 2012. PMID: 23218156

10

[Prevention of psychotic disorders; is the time ripe for intervention?].

de Haan L, Velthorst E, Nieman DH, Becker HE, de Lange MA, van der Gaag M. de Haan L, et al. Among authors: de lange ma. Ned Tijdschr Geneeskd. 2013;157(9):A5641. Ned Tijdschr Geneeskd. 2013. PMID: 23446157 Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

927 results

Search Page

Filters